Skip to main content
SpringerLink
Log in

Molecular pharmacology of 5-HT1D recognition sites: Radioligand binding studies in human, pig and calf brain membranes

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

  1. 1)

    The binding characteristics of [3H]5-HT (5-hydroxytryptamine, serotonin) were investigated in membrane preparations of several regions from calf, pig and human brain in the presence of 100 nmol/l 8-OH-DPAT (8-hydroxy-2[di-n-dipropylamino]tetralin) and 100 nmol/l mesulergine in order to mask 5-HT1A and 5-HT1C sites.

  2. 2)

    [3H]5-HT bound rapidly, reversibly and stereo-selectively to a population of high affinity recognition sites in membranes from pig caudate, calf caudate and human cortex, caudate and substantia nigra.

  3. 3)

    Saturation experiments carried out with [3H]5-HT in the presence of 100 nmol/l 8-OH-DPAT and 100 nmol/l mesulergine revealed that non-5-HT1A non-5-HT1C sites represented from 50 to more than 90% of the total 5-HT1 sites (determined with [3H]5-HT in the absence of 8-OHDPAT and mesulergine), depending on the tissue source.

  4. 4)

    The pharmacological profile of these sites was characterized in competition experiments performed with a variety of ligands in membranes of calf, pig and human caudate membranes. Under these conditions, [3H]5-HT labelled a population of “5-HT1-like” sites which display nanomolar affinity for tryptamines (5-carboxamidotryptamine > 5-HT >- 5-methoxytryptamine > tryptamine) and some ergolines (metergoline > methysergide). In contrast, these sites showed low affinity for drugs with high affinity and/or selectivity for 5-HT1A (8-OH-DPAT, buspirone), 5-HT1B (21-009, RU 24969), 5-HT1C (mesulergine, mianserin) and 5-HT2 sites (ketanserin, cinanserin).

  5. 5)

    Non-5-HT1A non-5-HT1C sites from calf, pig and human caudate membranes displayed a closely similar affinity profile as illustrated by the statistically very significant correlation parameters obtained when they were compared to one another. The pharmacological profile of these sites is different from that of 5-HT1A, 5-HT1B, 5-HT1C, 5-HT2 and 5-HT3 sites but is consistent with the pharmacology of a “5-HT1-like” receptor. It is very similar to that of the 5-HT1D site recently described in bovine brain by Heuring and Peroutka (1987).

  6. 6)

    The present findings demonstrate the presence and the pharmacological similarity of 5-HT1D sites in pig, calf and human brain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bouhelal R, Smounya L, Bockaert J (1988) 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra. Eur J Pharmacol (in press)

  • Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254

    Article  CAS  PubMed  Google Scholar 

  • Bradley PB, Engel G, Feniuk W, Fozard J, Humphrey PRA, Middlemiss DN, Mylecharane EJ, Richardson BP, Saxena PR (1986) Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25:563–576

    Google Scholar 

  • Charlton KG, Bond RA, Clarke DE (1986) An inhibitory prejunctional “5-HT1-like” receptor in the isolated perfused rat kidney: apparent distinction from the 5-HT1A, 5-HT1C and 5 HT1C subtypes. Naunyn-Schmiedeberg's Arch Pharmacol 332:8–15

    Google Scholar 

  • Clineschmidt BV, Reiss DR, Pettibone DJ, Robinson JL (1985) Characterization of 5-hydroxytryptamine receptors in rat stomach fundus. J Pharmacol Exp Ther 235:696–708

    Google Scholar 

  • Cohen ML, Wittenauer LA (1985) Further evidence that the serotonin receptor in the rat fundus is not 5-HT1A or 5-HT1B. Life Sci 38:1–5

    Google Scholar 

  • Conn PJ, Sanders-Bush E (1986) Agonist-induced phosphoinositide hydrolysis in choroid plexus. J Neurochem 47:1754–1760

    Google Scholar 

  • Conn PJ, Sanders-Bush E, Hoffman BJ, Hartig PR (1986) A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover. Proc Natl Acad Sci USA 83: 4086–4088

    Google Scholar 

  • Connor HE, Feniuk W, Humphrey PPA, Perren MJ (1986) Carboxamidotryptamine is a selective agonist at 5-HT receptors mediating vasodilatation and tachycardia in anaesthetized cats. Br J Pharmacol 87:417–426

    Google Scholar 

  • De Lean A (1979) SCTFIT, A computer program for simultaneous analysis of saturation and competition curve. Howard Hughes Medical Institute, Duke University. Medical Center Durham, North Carolina

    Google Scholar 

  • De Vivo M, Maayani S (1985) Inhibition of forskolin-stimulated adenylate cyclase activity by 5-HT receptor agonists. Eur J Pharmacol 119: 231–234

    Google Scholar 

  • De Vivo M, Maayani S (1986) Characterization of 5-hydroxytryptamine1A-receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea-pig and rat hippocampal membranes. J Pharmacol Exp Ther 238:248–253

    Google Scholar 

  • Gozlan H, El Mestikawy S, Pichat L, Glowinski J, Hamon M (1983) Identification of presynaptic serotonin autoreceptors by a new ligand: 3H-PAT. Nature (Lond) 305:140–142

    Google Scholar 

  • Heuring RE, Peroutka SJ (1987) Characterization of a novel 3H-5hydroxytryptamine binding site subtype in bovine brain membranes. J Neurosci 7:894–903

    Google Scholar 

  • Heuring RE, Schlegel JR, Peroutka SJ (1986) Species variations in RU 24969 interactions with non-5-HT1A binding sites. Eur J Pharmacol 122:279–282

    Google Scholar 

  • Hoyer D, Neijt HC (1987) Identification of serotonin 5-HT3 recognition sites by radioligand binding in NG 108–15 neuroblastoma-glioma cells. Eur J Pharmacol 143:291–292

    Google Scholar 

  • Hoyer D, Neijt HC (1988) Identification of serotonin 5-HT3 recognition sites in membranes of NIE-115 neuroblastoma cells by radioligand binding. Mol Pharmacol 33:303–309

    Google Scholar 

  • Hoyer D, Engel G, Kalkman HO (1985a) Characterization of the 5-HT1B recognition site in rat brain: binding studies with [125I]iodocyanopindolol. Eur J Pharmacol 118:1–12

    Google Scholar 

  • Hoyer D, Engel G, Kalkman HO (1985b) Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: Radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (−)-[125I]cyanopindolol, [3H]-mesulergine and [3H]ketanserin. Eur J Pharmacol 118:13–23

    Google Scholar 

  • Hoyer D, Pazos A, Probst A, Palacios JM (1986a) Serotonin receptors in the human brain. 1. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites. Brain Res 376:85–96

    Google Scholar 

  • Hoyer D, Pazos A, Probst A, Palacios JM (1986b) Serotonin receptors in the human brain. 11. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 receptors. Brain Res 376:97–107

    Article  CAS  PubMed  Google Scholar 

  • Hoyer D, Waeber C, Palacios JM (1987) Identification of a 5-HT1 recognition site in pig and human brain different from 5-HT1A, 5-HT1B and 5-HT1C. Br J Pharmacol 92:561P

  • Leysen JE, Niemegeers CJE, Tollenaere JP, Laduron PM (1978) Serotonergic component of neuroleptic receptors. Nature (London) 272:168–171

    Google Scholar 

  • Leysen JE, Niemegeers CJE, Van Nueten JM, Laduron PM (1982) [3H]Ketanserin (R41468), a selective 3H ligand for serotonin 2 receptor binding sites. Mol Pharmacol 21:301–314

    Google Scholar 

  • Markstein R, Hoyer D, Engel G (1986) 5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus. NaunynSchmiedeberg's Arch Pharmacol 333:335–341

    Google Scholar 

  • Middlemiss DN, Fozard JR (1983) 8-hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site. Eur J Pharmaco1 90:151–153

    Google Scholar 

  • Pazos A, Hoyer D, Palacios JM (1984) The binding of serotonergic ligands to the porcine choroid plexus: Characterization of a new type of serotonin recognition site. Eur J Pharmacol 106:539 -546

    Google Scholar 

  • Pazos A, Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. 1. Serotonin-1 receptors. Brain Res 346:205–230

    Google Scholar 

  • Pazos A, Probst A, Palacios JM (1987) Serotonin receptors in the human brain. III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience 21:97–122

    Article  CAS  PubMed  Google Scholar 

  • Pedigo NW, Yamamura HI, Nelson DL (1981) Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain. J Neurochem 36:220–226

    Google Scholar 

  • Peroutka SJ (1986) Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B and 5-HT1C binding sites in rat frontal cortex. J Neurochem 47:529–540

    Google Scholar 

  • Peroutka SJ, Snyder SH (1979) Multiple serotonin receptors: Differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. Mol Pharmacol 16:687–699

    CAS  PubMed  Google Scholar 

  • Saxena PR (1985) Heart rate responses to selective agonists of 5-hydroxytryptamine1 receptors in the spinal cat. Br J Pharmacol 86:599P

  • Scatchard G (1949) Attraction of proteins for small molecules and ions. Ann NY Acad Sci USA 51:660–679

    Google Scholar 

  • Schoeffter P, Waeber C, Palacios JM, and Hoyer D (1988) The 5HT1D receptor subtype is negatively coupled to adenylate cyclase in calf substantia nigra. Naunyn-Schmiedeberg's Arch Pharmacol 337:602–608

    Google Scholar 

  • Shenker A, Maayani S, Weinstein H, Green JP (1987) Pharmacological characterization of two 5-hydroxytryptamine receptors coupled to adenylate cyclase in guinea pig hippocampal membranes. Mol Pharmacol 31:357–367

    Google Scholar 

  • Waeber C, Died MM, Hoyer D, Probst A, Palacios JM (1988) Visualization of a novel serotonin recognition site (5-HT1D) in the human brain by autoradiography. Neurosci Lett 88:11–16

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Preclinical Research, Sandoz Ltd, Building 386/525, CH-4002, Basel, Switzerland

    C. Waeber, P. Schoeffter, J. M. Palacios & D. Hoyer

Authors
  1. C. Waeber
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Schoeffter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. M. Palacios
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Hoyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Send offprint requests to D. Hoyer at the above address

Rights and permissions

Reprints and permissions

About this article

Cite this article

Waeber, C., Schoeffter, P., Palacios, J.M. et al. Molecular pharmacology of 5-HT1D recognition sites: Radioligand binding studies in human, pig and calf brain membranes. Naunyn-Schmiedeberg's Arch Pharmacol 337, 595–601 (1988). https://doi.org/10.1007/BF00175783

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00175783

Key words

Search

Navigation